HeartSciences Inc HSCS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $2.56
- Day Range
- $2.43–2.90
- 52-Week Range
- $1.63–4.30
- Bid/Ask
- $2.65 / $2.83
- Shares Outstanding
- 3.29M
- Market Cap
- $9.02M
- Volume/Avg
- 103,999 / 2M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 622.42
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 12
- Website
- https://www.heartsciences.com
Valuation
|
Metric
|
HSCS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 3.07 |
Price/Sales | 622.42 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
HSCS
|
|---|---|
Quick Ratio | 0.80 |
Current Ratio | 1.19 |
Interest Coverage | −11.03 |
Quick Ratio
HSCS
Profitability
|
Metric
|
HSCS
|
|---|---|
Return on Assets (Normalized) | −123.72% |
Return on Equity (Normalized) | −309.33% |
Return on Invested Capital (Normalized) | −135.94% |
Return on Assets
HSCS
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|XW@>qv | LOCK|Pzxz | $155B | |||
| Stryker Corp
SYK
| LOCK|L@@YX%N | LOCK|N^ | $121B | |||
| Medtronic PLC
MDT
| LOCK|%>H@$! | LOCK|dQN^f | $103B | |||
| Boston Scientific Corp
BSX
| LOCK|!b%D@Sq | LOCK|rbcrm | $64B | |||
| Edwards Lifesciences Corp
EW
| LOCK|Cqvl@Z<^ | LOCK|%fTN? | $50B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|z?#@RV$ | LOCK|%< | $29B | |||
| DexCom Inc
DXCM
| LOCK|!&^^&%x< | LOCK|Rk%Q | $28B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|j^ | LOCK|?Tq | $26B | |||
| Steris PLC
STE
| LOCK|V&GjWD | LOCK|#^hp? | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|!%k<>?N! | LOCK|<>% | $17B |
United States